Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Update on CellPro's CEPRATE SC Stem Cell Concentration System

July 15, 1997

ArQule and Wyeth-Ayerst enter into drug discovery collaboration

July 15, 1997

ABS and Chinese Academy of Medical Science expand alliance

July 9, 1997

Oxford Molecular Group enters drug design agreement with Dainippon

July 7, 1997

BMS to develop products using CIMA's OraSolv oral delivery technology

July 3, 1997

Oncogene Science and Xenometrix alliance for drug discovery/lead optimization technologies

July 2, 1997

Corvas to strengthen anticancer program with option to acquire Vascular Genomics

July 2, 1997

Trega Biosciences and Ono to collaborate on melanocortin receptor pathway research

July 1, 1997

Megabios issued patent for aerosol gene delivery system

June 26, 1997

Neurogen and Tularik sign drug discovery agreement

June 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...